Federation Des Caisses Desjardins Du Quebec Neurocrine Biosciences Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 139,503 shares of NBIX stock, worth $17.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

139,503

Previous 109,735 27.13%

Holding current value

$17.5 Million

Previous $15.1 Million 6.31%

% of portfolio

0.08%

Previous 0.09%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $3.41 Million - $4.56 Million	29,768 Added 27.13%	139,503 $16.1 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $474,890 - $519,636	-3,629 Reduced 3.2%	109,735 $15.1 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $14.8 Million - $16.3 Million	113,364 New	113,364 $15.6 Billion
Q4 2023 Aug 14, 2024	SELL	$106.07 - $132.76 $492,695 - $616,670	-4,645 Reduced 2.63%	171,768 $22.6 Billion
Q3 2023 Aug 14, 2024	BUY	$94.02 - $117.1 $187,851 - $233,965	1,998 Added 1.15%	176,413 $19.8 Billion
Q2 2023 Aug 14, 2024	BUY	$89.53 - $104.87 $14.8 Million - $17.3 Million	164,905 Added 1734.02%	174,415 $16.4 Billion
Q1 2023 Aug 14, 2024	BUY	$94.11 - $123.02 $772,360 - $1.01 Million	8,207 Added 629.85%	9,510 $963 Million
Q4 2022 Aug 14, 2024	BUY	$106.72 - $127.06 $35,537 - $42,310	333 Added 34.33%	1,303 $156 Million
Q2 2022 Aug 14, 2024	SELL	$75.79 - $100.07 $8.24 Million - $10.9 Million	-108,765 Reduced 99.12%	970 $94.6 Million
Q4 2020 Aug 30, 2024	BUY	$86.91 - $108.33 $35,806 - $44,631	412 Added 13733.33%	415 $39.8 Million
Q3 2020 Aug 30, 2024	BUY	$96.16 - $135.15 $288 - $405	3 New	3 $288,000
Q2 2020 Aug 30, 2024	SELL	$85.09 - $130.36 $680 - $1,042	-8 Closed	0 $0
Q3 2019 Aug 30, 2024	SELL	$83.82 - $101.5 $9.2 Million - $11.1 Million	-109,727 Reduced 99.99%	8 $721,000
Q3 2018 Aug 30, 2024	BUY	$98.88 - $125.85 $76,928 - $97,911	778 New	778 $95.7 Million
Q2 2018 Aug 30, 2024	SELL	$75.3 - $105.99 $35,767 - $50,345	-475 Closed	0 $0
Q1 2018 Aug 30, 2024	SELL	$75.88 - $92.43 $8.29 Million - $10.1 Million	-109,260 Reduced 99.57%	475 $39.4 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Neurocrine Biosciences Inc Transaction History